Imagion Biosystems
(ASX) IBX
Imagion Biosystems Financials at a Glance
Market Cap
$10.79M
Revenue (TTM)
$2.69M
Net Income (TTM)
$6.38M
EPS (TTM)
$-0.02
P/E Ratio
-1.42
Dividend
$0.00
Beta (Volatility)
-0.02 (Low)
Dividend
$0.00
Beta (Volatility)
-0.02 (Low)
Price
$0.02
Volume
1,308,839
Open
$0.02
Price
$0.02
Volume
1,308,839
Open
$0.02
Previous Close
$0.02
Daily Range
$0.02 - $0.02
52-Week Range
$0.01 - $0.06
Dividend
$0.00
Beta (Volatility)
-0.02 (Low)
Price
$0.02
Volume
1,308,839
Open
$0.02
Previous Close
$0.02
Daily Range
$0.02 - $0.02
52-Week Range
$0.01 - $0.06
IBX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Imagion Biosystems
Industry
Healthcare Equipment and Supplies
Sector
Health CareCEO
Isaac J. Bright, MD, MBA
Website
www.imagionbiosystems.comHeadquarters
San Diego, CA 92121, US
IBX Financials
Key Financial Metrics (TTM)
Gross Margin
-23%
Operating Margin
-162%
Net Income Margin
-167%
Return on Equity
0%
Return on Capital
2%
Return on Assets
-2%
Earnings Yield
-70.42%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$10.79M
Shares Outstanding
490.59M
Volume
1.31M
Short Interest
0.00%
Avg. Volume
1.96M
Financials (TTM)
Gross Profit
$8.81K
Operating Income
$3.58M
EBITDA
$3.58M
Operating Cash Flow
$4.04M
Capital Expenditure
$4.00
Free Cash Flow
$4.04M
Cash & ST Invst.
$1.85M
Total Debt
$2.56M
Imagion Biosystems Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$4.37K
+99.4%
Gross Margin
0.00%
N/A
Market Cap
$10.79M
N/A
Market Cap/Employee
$981.18K
N/A
Employees
11
N/A
Net Income
$2.65M
+44.7%
EBITDA
$2.40M
+65.6%
Quarterly Fundamentals
Net Cash
$716.72K
+87.7%
Accounts Receivable
$34.20K
-53.6%
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$2.56M
-8.3%
Return on Assets
-2.11%
N/A
Return on Invested Capital
1.93%
N/A
Free Cash Flow
$2.27M
+8.0%
Operating Cash Flow
$2.27M
+1.3%